These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 35948138

  • 1. Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b/NS3 protease.
    Saqallah FG, Abbas MA, Wahab HA.
    Phytochemistry; 2022 Oct; 202():113362. PubMed ID: 35948138
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Investigating Lycotoxin-An1a (An1a), a defense antiviral peptide from Alopecosa nagpag venom as prospective anti-dengue agent against DENV-2 NS2B-NS3 protease.
    Purohit P, Barik D, Dansana J, Meher BR.
    Comput Biol Chem; 2024 Feb; 108():108005. PubMed ID: 38157660
    [Abstract] [Full Text] [Related]

  • 4. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
    Dwivedi VD, Tripathi IP, Mishra SK.
    J Vector Borne Dis; 2016 Feb; 53(2):156-61. PubMed ID: 27353586
    [Abstract] [Full Text] [Related]

  • 5. Exploring the therapeutic potential of DV-B-120 as an inhibitor of dengue virus infection.
    Huang Y-J, Cheng T-L, Wang Y-T, Chen C-S, Leu Y-L, Chang C-S, Ho C-H, Chao S-W, Li C-T, Chuang C-H.
    J Virol; 2024 Apr 16; 98(4):e0125823. PubMed ID: 38546211
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Orthoflaviviral Inhibitors in Clinical Trials, Preclinical In Vivo Efficacy Targeting NS2B-NS3 and Cellular Antiviral Activity via Competitive Protease Inhibition.
    Cavina L, Bouma MJ, Gironés D, Feiters MC.
    Molecules; 2024 Aug 27; 29(17):. PubMed ID: 39274895
    [Abstract] [Full Text] [Related]

  • 8. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
    Purohit P, Sahoo S, Panda M, Sahoo PS, Meher BR.
    J Mol Model; 2022 Oct 24; 28(11):365. PubMed ID: 36274116
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay.
    Yang CC, Hsieh YC, Lee SJ, Wu SH, Liao CL, Tsao CH, Chao YS, Chern JH, Wu CP, Yueh A.
    Antimicrob Agents Chemother; 2011 Jan 24; 55(1):229-38. PubMed ID: 20937790
    [Abstract] [Full Text] [Related]

  • 11. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.
    Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.
    Bioorg Med Chem Lett; 2017 Aug 01; 27(15):3586-3590. PubMed ID: 28539222
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
    Wu DW, Mao F, Ye Y, Li J, Xu CL, Luo XM, Chen J, Shen X.
    Acta Pharmacol Sin; 2015 Sep 01; 36(9):1126-36. PubMed ID: 26279156
    [Abstract] [Full Text] [Related]

  • 15. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
    Sarwar MW, Riaz A, Dilshad SMR, Al-Qahtani A, Nawaz-Ul-Rehman MS, Mubin M.
    BMC Struct Biol; 2018 Apr 19; 18(1):6. PubMed ID: 29673347
    [Abstract] [Full Text] [Related]

  • 16. Design, Synthesis, and in-vitro Protease Inhibition Assay of Linear Pentapeptides as Potential Dengue Virus NS2B/NS3 Protease Inhibitors.
    Abdalsatar Abdalrazaq N, Ezleen Binti Kamarulzaman E.
    Arch Razi Inst; 2022 Apr 19; 77(2):843-852. PubMed ID: 36284983
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthetic peptide optimization improves the inhibition of dengue NS2B-NS3 protease and dengue replication in vitro.
    Abdulrahman AY, Rothan HA, Khazali AS, Teoh TC, Daher AM, Yusof R.
    Acta Virol; 2019 Apr 19; 63(3):278-285. PubMed ID: 31507193
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.